New asthma shot tested in early safety trial
Disease control
Completed
This early-stage study tested a new injection called RC1416 in 40 adults with moderate to severe asthma. The main goal was to check the safety and side effects of different doses. Researchers also looked for early signs that the injection might help control asthma symptoms.
Phase: PHASE1 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC